Greenwich LifeSciences, Inc. GLSI
15.92 USD -0.54 (-3.28%)
At closeNov 4, 2026, 4:55 AM EST
16.41 +0.49 +3.08%
Pre-market · Nov 4, 4:55 AM ET
15.89 Day range 17.21
7.78 52-week range 34.10
- YTD
- -24.23%
- 1 year
- +96.79%
Analyst view
Price target (mean) 38.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 23, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 20, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 1, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jan 27, 2021 | Aegis Capital | Initiated | — | Buy |
| Jan 26, 2021 | Aegis Capital | Initiated | — | Buy |